ConjuGon Inc., a Madison company that develops technologies to combat antibiotic-resistant bacteria, has raised $375,000 of a proposed $5.75 million debt and equity financing round, according to a filing with federal securities regulators.
The money was raised from one investor, the filing said.
ConjuGon, which was founded in 2001, has raised a total of $3.6 million since 2010, according to www.formds.com. The company appears to be doing business now under the name Atterx Biotherapeutics. Read the full Milwaukee Journal Sentinel story here.
;
